HIM
BHC icon

Hillsdale Investment Management’s Bausch Health BHC Stock Holding History

Hillsdale Investment Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-524,892
Closed -$3.65M – 667
2025
Q4 		$3.65M Buy
+524,892
New +$3.45M 0.1% 271
2025
Q2 		– Sell
-1,670,930
Closed -$10.8M – 628
2025
Q1 		$10.8M Buy
1,670,930
+122,462
+8% +$880K 0.55% 27
2024
Q4 		$12.5M Buy
+1,548,468
New +$12.8M 0.63% 25
2024
Q3 		– Sell
-462,452
Closed -$3.23M – 603
2024
Q2 		$3.23M Sell
462,452
-2,946,931
-86% -$22.3M 0.25% 149
2024
Q1 		$36.1M Buy
3,409,383
+3,113,123
+1,051% +$27.2M 2.86% 2
2023
Q4 		$2.38M Buy
296,260
+232,160
+362% +$1.69M 0.19% 177
2023
Q3 		$528K Buy
+64,100
New +$553K 0.05% 250
2022
Q3 		– Sell
-1,000
Closed -$8K – 546
2022
Q2 		$8K Sell
1,000
-1,000
-50% -$14K ﹤0.01% 510
2022
Q1 		$46K Sell
2,000
-3,800
-66% -$92.9K ﹤0.01% 474
2021
Q4 		$160K Sell
5,800
-20,750
-78% -$555K 0.01% 417
2021
Q3 		$740K Buy
26,550
+1,200
+5% +$34K 0.06% 307
2021
Q2 		$743K Sell
25,350
-259,850
-91% -$7.87M 0.06% 297
2021
Q1 		$9.05M Buy
285,200
+282,200
+9,407% +$8.28M 0.76% 23
2020
Q4 		$62K Buy
3,000
+1,500
+100% +$28K 0.01% 424
2020
Q3 		$23K Sell
1,500
-5,100
-77% -$87.8K ﹤0.01% 463
2020
Q2 		$120K Buy
6,600
+2,400
+57% +$42.3K 0.01% 405
2020
Q1 		$65K Sell
4,200
-288,600
-99% -$6.96M 0.01% 429
2019
Q4 		$8.74M Sell
292,800
-65,400
-18% -$1.7M 0.76% 25
2019
Q3 		$7.82M Buy
358,200
+17,300
+5% +$396K 0.68% 34
2019
Q2 		$8.59M Buy
340,900
+7,500
+2% +$178K 0.85% 31
2019
Q1 		$8.24M Buy
333,400
+22,000
+7% +$525K 0.75% 37
2018
Q4 		$5.77M Buy
311,400
+170,800
+121% +$4.06M 0.68% 39
2018
Q3 		$3.61M Sell
140,600
-462,500
-77% -$10.6M 0.47% 46
2018
Q2 		$14M Buy
603,100
+274,500
+84% +$5.68M 1.72% 20
2018
Q1 		$5.23M Sell
328,600
-15,700
-5% -$292K 0.73% 32
2017
Q4 		$7.17M Buy
+344,300
New +$5.46M 1.16% 25
2017
Q3 		– Sell
-253,800
Closed -$4.41M – 477
2017
Q2 		$4.41M Buy
+253,800
New +$3.04M 0.86% 28
2016
Q4 		– Sell
-9,900
Closed -$243K – 481
2016
Q3 		$243K Buy
9,900
+1,630
+20% +$42.2K 0.06% 285
2016
Q2 		$167K Hold
8,270
– – 0.05% 301
2016
Q1 		$217K Hold
8,270
– – 0.07% 291
2015
Q4 		$836K Sell
8,270
-600
-7% -$67.4K 0.32% 44
2015
Q3 		$1.58M Hold
8,870
– – 0.53% 36
2015
Q2 		$1.97M Buy
8,870
+1,600
+22% +$355K 0.6% 35
2015
Q1 		$1.44M Buy
7,270
+1,500
+26% +$266K 0.37% 50
2014
Q4 		$826K Buy
5,770
+2,700
+88% +$363K 0.21% 73
2014
Q3 		$402K Sell
3,070
-12,700
-81% -$1.51M 0.13% 112
2014
Q2 		$1.99M Sell
15,770
-2,300
-13% -$293K 0.45% 41
2014
Q1 		$2.38M Sell
18,070
-5,000
-22% -$684K 0.67% 27
2013
Q4 		$2.71M Sell
23,070
-1,200
-5% -$131K 0.79% 24
2013
Q3 		$2.53M Buy
24,270
+7,300
+43% +$711K 0.75% 26
2013
Q2 		$1.46M Buy
+16,970
New +$1.34M 0.48% 32

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hillsdale Investment Management's BHC Position: Q1 2026 in Review

Hillsdale Investment Management sold out of Bausch Health (BHC) in Q1 2026, closing a stake of 524,892 shares — an estimated $3.65M sold.

Hillsdale Investment Management first reported a position in BHC in Q2 2013 and held it in 41 quarters. The position peaked at $36.1M in Q1 2024. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Hillsdale Investment Management reported no remaining Bausch Health position as of Q1 2026 after selling out during the quarter.
  • Hillsdale Investment Management sold 524,892 Bausch Health shares in Q1 2026, an estimated $3.65M.
  • Hillsdale Investment Management first reported a position in Bausch Health in Q2 2013 and held it in 41 quarters.
  • Hillsdale Investment Management's Bausch Health position peaked at $36.1M in Q1 2024.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.